A Study of QL1706H in Patients With Advanced Solid Tumors

NCT06047431 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: QL1706H

Sponsor

Qilu Pharmaceutical Co., Ltd.